Furthermore, the activation level of tumor‐infiltrated T cells, evaluated by the CD69 expression level, was decreased in mice with anti‐CD4 treatment in comparison with IgG treatment (Figure 6k; Figure S10e, Supporting Information). This evidence concerns the gene CD69 and neoplasm.